Anal cancer

Apr 20, 2020

Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse(TM) Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors

Feb 03, 2020

Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections

Sep 18, 2019

HPV Associated Disorders Market Size Worth $23.2 Billion By 2026: Grand View Research, Inc.

Aug 19, 2019

Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia

May 30, 2019

Orion Biotechnology's Chief Medical Officer to Present at the American Society of Clinical Oncology (ASCO) Meeting in Chicago

Jan 29, 2019

uBiome Awards Grant to UCSF Researchers to Study Association Between Anal Microbiome Composition and Anal Cancer

Nov 08, 2018

Advances in radiation therapy extend and improve lives of patients with anal cancer, studies find

Nov 01, 2018

Biomarker blood test accurately confirms remission in patients with HPV-associated oral cancer

Mar 12, 2018

Poorer Socioeconomic Status Predicts Lower Survival in Patients with Anal Cancer

Mar 03, 2018

Sunday, March 4th, Marks the 1st Annual International HPV Awareness Day; Spreading Knowledge and Prevention Around the Globe

Aug 09, 2017

Black Men Have Lowest Survival Rates Among Patients with Anal Cancer